Correction to: Cost-Utility and Budget Impact Analysis for Stopping the Inappropriate Use of Proton Pump Inhibitors After Cessation of NSAID or Low‑Dose Acetylsalicylic Acid Treatment.


Journal

Drugs & aging
ISSN: 1179-1969
Titre abrégé: Drugs Aging
Pays: New Zealand
ID NLM: 9102074

Informations de publication

Date de publication:
Jan 2020
Historique:
pubmed: 7 11 2019
medline: 7 11 2019
entrez: 6 11 2019
Statut: ppublish

Résumé

Errors were subsequently identified in the article, and the following corrections should be noted.

Identifiants

pubmed: 31686404
doi: 10.1007/s40266-019-00719-z
pii: 10.1007/s40266-019-00719-z
pmc: PMC6965039
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

75

Commentaires et corrections

Type : ErratumFor

Auteurs

Sek Hung Chau (SH)

Department of Clinical Pharmacology and Pharmacy, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. s.chau@amsterdamumc.nl.

Reinier Luuk Sluiter (RL)

Department for Health Evidence, Radboud University Medical Center, Geert Grooteplein 21, Nijmegen, The Netherlands.

Jacqueline Geertruida Hugtenburg (JG)

Department of Clinical Pharmacology and Pharmacy, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.

Michel Wensing (M)

Radboud University Medical Center, Scientific Institute for Quality of Healthcare (IQ Healthcare), Geert Grooteplein 21, Nijmegen, The Netherlands.
Department of General Practice and Health Services Research, Heidelberg University, Im Neuenheimer Feld 130.3, Heidelberg, Germany.

Wietske Kievit (W)

Department for Health Evidence, Radboud University Medical Center, Geert Grooteplein 21, Nijmegen, The Netherlands.

Martina Teichert (M)

Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, Leiden, The Netherlands.

Classifications MeSH